<DOC>
	<DOCNO>NCT01253577</DOCNO>
	<brief_summary>The purpose study assess safety efficacy Propel mometasone furoate implant use follow Functional Endoscopic Sinus Surgery ( FESS ) patient Chronic Sinusitis ( CS ) .</brief_summary>
	<brief_title>A Clinical Evaluation Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery Patients With Chronic Sinusitis</brief_title>
	<detailed_description>The purpose study assess safety efficacy Propel mometasone furoate implant use follow Functional Endoscopic Sinus Surgery ( FESS ) patient Chronic Sinusitis ( CS ) . The Propel implant design provide mechanical space function within sinus anatomy separate mucosal tissue , provide stabilization middle turbinate , thereby prevent tissue adhesion form . The implant coat small amount mometasone furoate ( corticosteroid ) order help minimize post surgical inflammation within supported tissue . The study utilizes intra-patient control design assess safety efficacy drug-coated implant compare non-drug coat implant identical appearance .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Patient bilateral chronic sinusitis confirm CT scan define inflammation mucosa nose paranasal sinuses least 8 consecutive week ' duration . Patient indicate consented FESS . FESS successfully complete without significant complication opinion physician would confound study result patient 's anatomy remain amenable Sinus Stent placement . CT Imaging CS diagnosis confirm documented CT Scan within 6 month procedure . Patient minimum total CT score ( LundMackay method ) 6 . â€¢ Patient bilateral ethmoid sinus disease confirm CT. insulin dependent diabetic oral steroid dependent condition glaucoma , ocular hypertension , posterior subcapsular cataract middle turbinate resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>